Recently, integrative molecular classifications based on DNA methylation profiling for meningiomas have been developed rapidly, which have all been proven to better predict clinical outcomes.[21, 27, 28] Positivity of SULT1E1+ subpopulation might be a new factor to consider for the risk evaluation of the patients with meningioma. Here, SULT1E1 is linked to meningioma.